Supplementary Figure 1 from Chemotherapy Dosing Schedule Influences Drug Resistance Development in Ovarian Cancer Article Swipe
Raquel De Souza
,
Payam Zahedi
,
Rose M. Badame
,
Christine Allen
,
Micheline Piquette‐Miller
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1535-7163.22496332.v1
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1535-7163.22496332.v1
Supplementary Figure 1 from Chemotherapy Dosing Schedule Influences Drug Resistance Development in Ovarian Cancer
Related Topics
Concepts
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/1535-7163.22496332.v1
- https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Chemotherapy_Dosing_Schedule_Influences_Drug_Resistance_Development_in_Ovarian_Cancer/22496332/1/files/39954346.pdf
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4362479539
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4362479539Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1535-7163.22496332.v1Digital Object Identifier
- Title
-
Supplementary Figure 1 from Chemotherapy Dosing Schedule Influences Drug Resistance Development in Ovarian CancerWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-04-03Full publication date if available
- Authors
-
Raquel De Souza, Payam Zahedi, Rose M. Badame, Christine Allen, Micheline Piquette‐MillerList of authors in order
- Landing page
-
https://doi.org/10.1158/1535-7163.22496332.v1Publisher landing page
- PDF URL
-
https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Chemotherapy_Dosing_Schedule_Influences_Drug_Resistance_Development_in_Ovarian_Cancer/22496332/1/files/39954346.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Chemotherapy_Dosing_Schedule_Influences_Drug_Resistance_Development_in_Ovarian_Cancer/22496332/1/files/39954346.pdfDirect OA link when available
- Concepts
-
Dosing, Ovarian cancer, Schedule, Chemotherapy, Medicine, Oncology, Drug, Drug resistance, Cancer chemotherapy, Internal medicine, Cancer, Pharmacology, Computer science, Biology, Microbiology, Operating systemTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4362479539 |
|---|---|
| doi | https://doi.org/10.1158/1535-7163.22496332.v1 |
| ids.doi | https://doi.org/10.1158/1535-7163.22496332.v1 |
| ids.openalex | https://openalex.org/W4362479539 |
| fwci | |
| type | preprint |
| title | Supplementary Figure 1 from Chemotherapy Dosing Schedule Influences Drug Resistance Development in Ovarian Cancer |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10550 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9315999746322632 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2743 |
| topics[0].subfield.display_name | Reproductive Medicine |
| topics[0].display_name | Ovarian cancer diagnosis and treatment |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2777288759 |
| concepts[0].level | 2 |
| concepts[0].score | 0.8791645765304565 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q4164182 |
| concepts[0].display_name | Dosing |
| concepts[1].id | https://openalex.org/C2780427987 |
| concepts[1].level | 3 |
| concepts[1].score | 0.8071103096008301 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q172341 |
| concepts[1].display_name | Ovarian cancer |
| concepts[2].id | https://openalex.org/C68387754 |
| concepts[2].level | 2 |
| concepts[2].score | 0.7304370999336243 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q7271585 |
| concepts[2].display_name | Schedule |
| concepts[3].id | https://openalex.org/C2776694085 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6410415172576904 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q974135 |
| concepts[3].display_name | Chemotherapy |
| concepts[4].id | https://openalex.org/C71924100 |
| concepts[4].level | 0 |
| concepts[4].score | 0.5633387565612793 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[4].display_name | Medicine |
| concepts[5].id | https://openalex.org/C143998085 |
| concepts[5].level | 1 |
| concepts[5].score | 0.5262289047241211 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[5].display_name | Oncology |
| concepts[6].id | https://openalex.org/C2780035454 |
| concepts[6].level | 2 |
| concepts[6].score | 0.47267112135887146 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q8386 |
| concepts[6].display_name | Drug |
| concepts[7].id | https://openalex.org/C114851261 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4680575728416443 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q12147416 |
| concepts[7].display_name | Drug resistance |
| concepts[8].id | https://openalex.org/C2983288658 |
| concepts[8].level | 3 |
| concepts[8].score | 0.4335036277770996 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q974135 |
| concepts[8].display_name | Cancer chemotherapy |
| concepts[9].id | https://openalex.org/C126322002 |
| concepts[9].level | 1 |
| concepts[9].score | 0.3898718059062958 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[9].display_name | Internal medicine |
| concepts[10].id | https://openalex.org/C121608353 |
| concepts[10].level | 2 |
| concepts[10].score | 0.3564026951789856 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[10].display_name | Cancer |
| concepts[11].id | https://openalex.org/C98274493 |
| concepts[11].level | 1 |
| concepts[11].score | 0.30629825592041016 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[11].display_name | Pharmacology |
| concepts[12].id | https://openalex.org/C41008148 |
| concepts[12].level | 0 |
| concepts[12].score | 0.15803584456443787 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[12].display_name | Computer science |
| concepts[13].id | https://openalex.org/C86803240 |
| concepts[13].level | 0 |
| concepts[13].score | 0.1394633948802948 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[13].display_name | Biology |
| concepts[14].id | https://openalex.org/C89423630 |
| concepts[14].level | 1 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7193 |
| concepts[14].display_name | Microbiology |
| concepts[15].id | https://openalex.org/C111919701 |
| concepts[15].level | 1 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q9135 |
| concepts[15].display_name | Operating system |
| keywords[0].id | https://openalex.org/keywords/dosing |
| keywords[0].score | 0.8791645765304565 |
| keywords[0].display_name | Dosing |
| keywords[1].id | https://openalex.org/keywords/ovarian-cancer |
| keywords[1].score | 0.8071103096008301 |
| keywords[1].display_name | Ovarian cancer |
| keywords[2].id | https://openalex.org/keywords/schedule |
| keywords[2].score | 0.7304370999336243 |
| keywords[2].display_name | Schedule |
| keywords[3].id | https://openalex.org/keywords/chemotherapy |
| keywords[3].score | 0.6410415172576904 |
| keywords[3].display_name | Chemotherapy |
| keywords[4].id | https://openalex.org/keywords/medicine |
| keywords[4].score | 0.5633387565612793 |
| keywords[4].display_name | Medicine |
| keywords[5].id | https://openalex.org/keywords/oncology |
| keywords[5].score | 0.5262289047241211 |
| keywords[5].display_name | Oncology |
| keywords[6].id | https://openalex.org/keywords/drug |
| keywords[6].score | 0.47267112135887146 |
| keywords[6].display_name | Drug |
| keywords[7].id | https://openalex.org/keywords/drug-resistance |
| keywords[7].score | 0.4680575728416443 |
| keywords[7].display_name | Drug resistance |
| keywords[8].id | https://openalex.org/keywords/cancer-chemotherapy |
| keywords[8].score | 0.4335036277770996 |
| keywords[8].display_name | Cancer chemotherapy |
| keywords[9].id | https://openalex.org/keywords/internal-medicine |
| keywords[9].score | 0.3898718059062958 |
| keywords[9].display_name | Internal medicine |
| keywords[10].id | https://openalex.org/keywords/cancer |
| keywords[10].score | 0.3564026951789856 |
| keywords[10].display_name | Cancer |
| keywords[11].id | https://openalex.org/keywords/pharmacology |
| keywords[11].score | 0.30629825592041016 |
| keywords[11].display_name | Pharmacology |
| keywords[12].id | https://openalex.org/keywords/computer-science |
| keywords[12].score | 0.15803584456443787 |
| keywords[12].display_name | Computer science |
| keywords[13].id | https://openalex.org/keywords/biology |
| keywords[13].score | 0.1394633948802948 |
| keywords[13].display_name | Biology |
| language | en |
| locations[0].id | doi:10.1158/1535-7163.22496332.v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Chemotherapy_Dosing_Schedule_Influences_Drug_Resistance_Development_in_Ovarian_Cancer/22496332/1/files/39954346.pdf |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1535-7163.22496332.v1 |
| locations[1].id | pmh:oai:figshare.com:article/22496332 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306400572 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[1].source.host_organization | https://openalex.org/I196829312 |
| locations[1].source.host_organization_name | La Trobe University |
| locations[1].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[1].license | cc-by |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | https://openalex.org/licenses/cc-by |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Chemotherapy_Dosing_Schedule_Influences_Drug_Resistance_Development_in_Ovarian_Cancer/22496332 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5057874572 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-5502-6329 |
| authorships[0].author.display_name | Raquel De Souza |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Raquel De Souza |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5033070603 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-6636-4534 |
| authorships[1].author.display_name | Payam Zahedi |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Payam Zahedi |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5015151704 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Rose M. Badame |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Rose M. Badame |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5086834252 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-4916-3965 |
| authorships[3].author.display_name | Christine Allen |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Christine Allen |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5013796776 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-3847-8224 |
| authorships[4].author.display_name | Micheline Piquette‐Miller |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Micheline Piquette-Miller |
| authorships[4].is_corresponding | False |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Chemotherapy_Dosing_Schedule_Influences_Drug_Resistance_Development_in_Ovarian_Cancer/22496332/1/files/39954346.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Supplementary Figure 1 from Chemotherapy Dosing Schedule Influences Drug Resistance Development in Ovarian Cancer |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10550 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9315999746322632 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2743 |
| primary_topic.subfield.display_name | Reproductive Medicine |
| primary_topic.display_name | Ovarian cancer diagnosis and treatment |
| related_works | https://openalex.org/W3166797618, https://openalex.org/W4210913627, https://openalex.org/W2915644342, https://openalex.org/W2159406923, https://openalex.org/W2911677179, https://openalex.org/W4288738052, https://openalex.org/W3034286462, https://openalex.org/W4391224393, https://openalex.org/W2375408391, https://openalex.org/W3200600120 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1158/1535-7163.22496332.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Chemotherapy_Dosing_Schedule_Influences_Drug_Resistance_Development_in_Ovarian_Cancer/22496332/1/files/39954346.pdf |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1535-7163.22496332.v1 |
| primary_location.id | doi:10.1158/1535-7163.22496332.v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Chemotherapy_Dosing_Schedule_Influences_Drug_Resistance_Development_in_Ovarian_Cancer/22496332/1/files/39954346.pdf |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1535-7163.22496332.v1 |
| publication_date | 2023-04-03 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.1 | 2 |
| abstract_inverted_index.in | 11 |
| abstract_inverted_index.Drug | 8 |
| abstract_inverted_index.from | 3 |
| abstract_inverted_index.Cancer | 13 |
| abstract_inverted_index.Dosing | 5 |
| abstract_inverted_index.Figure | 1 |
| abstract_inverted_index.Ovarian | 12 |
| abstract_inverted_index.Schedule | 6 |
| abstract_inverted_index.Influences | 7 |
| abstract_inverted_index.Resistance | 9 |
| abstract_inverted_index.Development | 10 |
| abstract_inverted_index.Chemotherapy | 4 |
| abstract_inverted_index.Supplementary | 0 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 5 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.47999998927116394 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.12723752 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |